secwatch.observer — SEC 8-K summary
======================================

Issuer:     Black Diamond Therapeutics, Inc. (BDTX)
CIK:        0001701541
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001104659-24-004802
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Board member Rajeev Shah resigns from Black Diamond Therapeutics board effective Jan 17, 2024
--------------------------------------------------------------------------------

- Rajeev Shah resigned from the Board and its Audit Committee, effective immediately on January 17, 2024.
- Shah had served as a director since December 2018; resignation not due to any disagreement with the Company.
- No replacement director has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701541/000110465924004802/0001104659-24-004802-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701541/000110465924004802/tm243561d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-004802

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer